These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8043416)

  • 1. Triggering of bullous pemphigoid by iodine.
    Piletta P; Rieckhoff L; Saurat JH
    Br J Dermatol; 1994 Jul; 131(1):145-7. PubMed ID: 8043416
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept.
    Kluk J; Goulding JM; Bhat J; Finch TM
    Clin Exp Dermatol; 2011 Dec; 36(8):871-3. PubMed ID: 21623885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and contamination of iodophors.
    Lange WE
    J Am Acad Dermatol; 1984 Jun; 10(6):1065-6. PubMed ID: 6736326
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of levetiracetam induced bullous pemphigoid.
    Karadag AS; Bilgili SG; Calka O; Onder S; Kosem M; Burakgazi-Dalkilic E
    Cutan Ocul Toxicol; 2013 Jun; 32(2):176-8. PubMed ID: 23030621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide-induced bullous pemphigoid: case report and review of literature.
    Lee JJ; Downham TF
    J Drugs Dermatol; 2006 Jun; 5(6):562-4. PubMed ID: 16774111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mefenamic acid-induced bullous pemphigoid.
    Shepherd AN; Ferguson J; Bewick M; Bouchier IA
    Postgrad Med J; 1986 Jan; 62(723):67-8. PubMed ID: 3540922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous pemphigoid and penicillamine.
    Weller R; White MI
    Clin Exp Dermatol; 1996 Mar; 21(2):121-2. PubMed ID: 8759198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous pemphigoid following therapy with an oral beta-blocker.
    Perry A; Sparling JD; Pennington M
    J Drugs Dermatol; 2005; 4(6):746-8. PubMed ID: 16302561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine and lithium-induced hypothyroidism. Documentation of synergism.
    Shopsin B; Shenkman L; Blum M; Hollander CS
    Am J Med; 1973 Nov; 55(5):695-9. PubMed ID: 4749208
    [No Abstract]   [Full Text] [Related]  

  • 10. Bullous pemphigoid in an infant using complementary medicine.
    Purvis DJ; Bhogal BS; Harper JI
    Clin Exp Dermatol; 2009 Mar; 34(2):195-8. PubMed ID: 19187301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucocutaneous bullous pemphigoid induced by valsartan. A clinical case].
    Femiano F
    Minerva Stomatol; 2003 Apr; 52(4):187-90. PubMed ID: 12874527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An unusual case: hemorrhagic bullous pemphigoid following furosemide treatment].
    Ingber A; David M; Feuerman EJ
    Z Hautkr; 1986 Nov; 61(21):1554-6. PubMed ID: 3544545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of the level of iodine content in milk caused by the penetration of same from iodophoric preparations used during milking].
    Sololowska R; Fuks T; Olejnik E
    Rocz Panstw Zakl Hig; 1976; 27(1):33-40. PubMed ID: 946331
    [No Abstract]   [Full Text] [Related]  

  • 14. Bullous pemphigoid in infant post vaccination: Myth or reality?
    Neri I; Greco A; Bassi A; Orgaz-Molina J; Balestri R; Oranges T; Patrizi A; de Martino M
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):295-9. PubMed ID: 26684642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone and bullous pemphigoid.
    Wijeratne C; Webster P
    Am J Psychiatry; 1996 May; 153(5):735. PubMed ID: 8615430
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bullous pemphigoid induced by photochemotherapy of psoriasis. Apropos of 2 cases, with a review of the literature].
    Brun P; Baran R
    Ann Dermatol Venereol; 1982; 109(5):461-8. PubMed ID: 6753695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database.
    Béné J; Moulis G; Bennani I; Auffret M; Coupe P; Babai S; Hillaire-Buys D; Micallef J; Gautier S;
    Br J Dermatol; 2016 Aug; 175(2):296-301. PubMed ID: 27031194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system.
    Aggarwal P
    Expert Opin Drug Saf; 2019 Jul; 18(7):623-633. PubMed ID: 31088310
    [No Abstract]   [Full Text] [Related]  

  • 19. Bullous pemphigoid induced by vildagliptin: a report of three cases.
    Béné J; Jacobsoone A; Coupe P; Auffret M; Babai S; Hillaire-Buys D; Jean-Pastor MJ; Vonarx M; Vermersch A; Tronquoy AF; Gautier S
    Fundam Clin Pharmacol; 2015 Feb; 29(1):112-4. PubMed ID: 24861252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between drugs and bullous pemphigoid.
    Tan CW; Pang Y; Sim B; Thirumoorthy T; Pang SM; Lee HY
    Br J Dermatol; 2017 Feb; 176(2):549-551. PubMed ID: 27868192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.